Our Team
Management, Directors, Advisory Boards
Management
Yoav Raiter, CEO & Director
Yoav’s wide-spanning career has focused on developing innovative software and medical device products mainly for start-ups and fast-growing companies. Yoav developed processes to ensure delivery of clients needs at high quality, improved operations, and business strategy.
Prior to joining Relay Medical, Yoav was project manager for strategic accounts at StarFish Medical and Director of project management and business development at Kangaroo Group. Yoav has additionally held several prominent positions managing large scale ERP product development and implementation projects for broadcasters in Canada and the US for Pilat Media and SintecMedia.
Yoav received an MBA, Specialized in High Tech Innovation Strategy, from Haifa University in Israel and B.Sc., Industrial Engineering, major: Project Management, Business Development and Information Systems from the Technion at Haifa, Israel.
W. Clark Kent, President & Director
Clark is a capital markets professional with extensive experience leading corporate development and finance initiatives in the natural resources, technology and life science industries. For over a decade he has advised emerging companies on strategic planning, finance and recruitment in the North American and international marketplace. Clark began his career with a boutique investment firm where he focused on client relations and marketing.
Tom Glawdel, CSO
Mr. Glawdel is a decorated PhD in Mechanical and Mechatronics Engineering from the University of Waterloo with experience in the development of microfluidic, molecular diagnostics, RUO products and medical devices both internal and through strategic research partnerships. Tom has authored 30+ academic publications and patent applications.
Chris Hopkins, CFO
Chris has over 25 years of leadership and financial management experience in the capital markets. He has spent most of his career in senior roles with public mining companies, including U.S. Silver, Rio Algom, BHP Billiton, Suncor and several Canadian and international companies.
He has a Bachelor of Commerce from the University of Toronto, and a Chartered Accountant designation and MBA from the Schulich School of Business at York University.
Paul Glavina, VP In Vitro Diagnostics
Paul is a technical and business leader with a record of bringing disruptive, world-class in vitro diagnostics products from concept to the marketplace and ensuring continued market growth and expansion. He was a leader for over 25 years with Abbott Point of Care and its precursor, i-STAT Corporation, designing, developing, manufacturing, and marketing the world’s first handheld blood gas and electrolyte analyzer. He is an inventor with a number of patents and an Abbott Chairman’s Award.
Paul has also been a leader in the broader diagnostics technical and professional community, including as a member of United States Technical Advisory Group to ISO TC 212, an advisor and contributing author to multiple Clinical and Laboratory Standards Institute projects, a member of the Laboratory Working Group, National Kidney Disease Education Program, a member of the CLIA Working Group, Advanced Medical Technology Association (AdvaMed), and a member of the Technical Advisory Committee, Canadian Microelectronics Corporation.
Vadim Kositksy, VP AI & Data Science
Mr. Kositsky has over 15 years of senior level experience specializing in the development of innovative artificial intelligence projects in computer vision and machine learning and has extensive knowledge in AI, cloud-based data science, as well as android, R&D and software development.
Mr. Kositsky has worked in multidisciplinary fields including geophysics, ophthalmic optics, and medical diagnostics. Prior to joining Relay Medical in 2019, he was a lead developer at Fio Corporation, he worked as team lead, senior software and algorithms developer for the integration of motion and eye tracking and system image processing at Shamir Optical, and is formerly an algorithms developer for the Israeli Defense Forces and for the Navy, in the Hydrography branch. Mr. Kositsky has a MSc in Medical Physics from Tel Aviv University and a BA in Physics from Technion - Israel Institute of Technology.
Board of Directors
Sid Thomas
Mr. Thomas is a successful business leader with executive senior management expertise in software development, software project management and sales development. He was a significant leader in the growth of DMC Inc, a developer of a suite of software products targeted to the financial services sector, until its sale in 2000. At the time of the sale he was President of the Company. In 2003, he founded VERAX Solutions Inc. a software development company, and was instrumental in its substantial growth until its successful sale in 2017. It is expected that Mr. Thomas’ expertise in software growth strategies and execution will provide invaluable support for the Company as it enters the next stage of its growth, with a much greater emphasis on software development capabilities.
Michael Minder
Michael Minder is a seasoned finance professional with over 15 years of international banking experience. He held senior leadership roles in Asset and Wealth Management for Credit Suisse Group in both Switzerland and North America, managing assets of high net worth accounts. In 1998 he left the Credit Suisse Group to form his own firm providing international investment banking and investor relations advisory services to numerous U.S., Canadian, and European listed companies.
Greg Van Staveren
Mr. Van Staveren, CPA is the President of Strategic Financial Services, a private company providing ongoing business advisory and support services to emerging companies. In addition to advisory roles, he has acted as Chief Financial Officer, Chief Operating Officer or as a member of Board of Directors for many private and public companies and has been a key part of management for several very successful high growth companies. Until 1998, he was Partner at KPMG, a professional services firm where he provided compliance, advisory and strategic services for his clients. It is expected that Mr. Van Staveren’s management expertise in supporting developing companies will support the growing structures and systems needed for Relay’s growth.
Clinical Advisory Board
Murray Berall
Dr. Berall is a Nephrologist and Sleep Medicine Specialist at the Vaughan Heart Institute and Humber River Hospital. Born and raised in Halifax, Nova Scotia, he studied genetics at McGill University and attended medical school at Dalhousie University. He completed his post-graduate education in Internal Medicine and Nephrology at the University of Toronto. He was the first Director of Dialysis at HRH and helped oversee the creation of the initial program. He has helped develop teaching tools for specialists and family doctors on the management of CKD, Diabetes, Lipids and Hypertension, Hyponatremia, Gout and Atrial Fibrillation. Dr. Berall completed his training in sleep medicine, attending the Stanford School of Sleep Medicine in Paolo Alto, California. He is actively engaged in research in the field of sleep medicine, the impact of fluid shifts on OSA and the relationship to ESRD and CKD patients.
Dr. Tejal Patel
Dr. Patel is a clinical associate professor at the University of Waterloo and her research interests are in pharmacotherapeutic management of neurological conditions, in particular dementia, epilepsy and Parkinson's disease. Her current research includes the assessment, classification and management of drug related problems in persons presenting with cognitive impairment as well as the frail elderly in primary care settings with a particular focus on medication management capacity and adherence to medications.
Dr. Michael M. Greenberg
Michael co-founded and leads Fio Corporation, which pioneered and commercialized a data-and-device platform that brings to community-based healthcare settings below the level of hospitals the same level of quality in diagnostics, treatment, and tracking that is currently available mostly in hospitals. This platform – Fionet – comprises mobile devices that provide quality-controlled diagnosis and treatment guidance at the point of care, integrated with real-time tracking and reporting for remote supervisors, managers, public health agencies, and funders. Previously, Michael built a global champion in medical imaging software: one billion medical imaging patient scans were performed worldwide with this technology. He led that company from startup to a public offering on NASDAQ and the Toronto Stock Exchange, the Profit 100 list, the top-performing stock on the Toronto Stock Exchange, winning the Canada Export Award, and the Canada Award for Business Excellence in Innovation. Eighteen months after Michael left the company, it was sold in a deal worth 500 million dollars, and later acquired by IBM. Michael received a medical degree from the University of Pennsylvania and went on to a neurosurgery residency and a National Institutes of Health biophysics post-doctoral fellowship at the University of Toronto.
Phillip Stücklin
Philipp is a Project Manager and Senior Systems Engineer with 12 years of experience interacting with stakeholders & key opinion leaders in medtech and start-up environments. He has successfully led many medical device development projects for clients in B2B settings under an ISO 13485 quality management system and is passionate about innovating--both in product design and in continuous process improvement. Having lived and worked in different countries and cultures, Philipp easily communicates on a professional level in four languages and has an excellent grasp of international collaborations. He is a team player with an analytical and methodical work style and possesses quick comprehension skills.
Strategic Advisory Board
Colin Greenaway
Mr. Colin Greenaway has 37 years of policing experience, and currently occupies a senior leadership role with one of Canada’s largest policing agencies. He is passionate about his work in specialized emergency response and is drawn to challenges, change and working within an organization that makes a difference in public health and safety. Colin has strong leadership, interpersonal and decision-making skills with broad experience in the public sector. Colin has advised and contributed to companies in the medical field; specifically, an innovative concussion clinic and an artificial intelligence-based genomics company.
Barack Carmon
Mr. Carmon is a life-long technology entrepreneur, with multiple successful exits and over 30 years of experience. He has co-founded and served in executive technical, operational, financial and business development positions in four companies. Currently he is the Managing director of JBCI Holdings, an advisory firm which specializes in fundraising, business development and strategic planning and focuses on North American and Israeli-related opportunities. He is also an advisor to a number of family offices and funds. Barak earned a Bachelor's in Economics with a specialization in computing from UCLA and Tel Aviv University and an MBA from Tel Aviv University, both magna cum laude.
Robert Carducci
Robert Carducci is a seasoned marketing executive with over a decade of leadership experience building iconic global brands including Delissio, Drumstick, Smarties and KitKat. Most recently Rob served as Marketing Director for the largest cannabis information website in the world Leafly.com, owned by Leafly Holdings, Inc. Robert is currently the Chief Commercial Officer of Glow LifeTech.
Robert Cash, JD
Robert is a co-founder, President and CEO of Skye Capital and its related companies and a partner in Skye Trillium CMBS. Robert has been involved over the past 20 years in the syndication, ownership, management and development of numerous business opportunities in Canada. Robert leads Skye Capital in its initiatives and in the investigation and structuring of new opportunities, managing relationships and due diligence. Robert has transacted business as principal with numerous high-profile Canadian companies, has provided advisory services to a variety of public and private companies and has provided legal services to the Province of Ontario, several municipalities and Boards of Education. Formerly, Robert was a partner with preeminent Canadian law firm, specializing in Real Estate, Finance and Corporate-Commercial Law. Robert has lectured at the Law Society of Upper Canada, has authored various articles on matters of interest to the legal bar and has taught at the Ontario Bar Admission Course.
Shlomit Dekel
Shlomit Dekel is President of Fio Corporation, which she co-founded with Dr. Michael Greenberg. Previously, Ms. Dekel held a number of executive roles at NASDAQ-traded, medical imaging software leader Cedara Software Corp., including VP Sales, VP Business Development, General Manager of the Surgical Division, and director of a joint venture with Mitsui, Japan’s largest industrial company. Ms. Dekel oversaw projects in mergers and acquisitions and divestments, and built strategic alliances and long-term partnerships with major multinational healthcare companies, including B. Braun, Biomet, Elekta, Hitachi, GE, McKesson, Medtronic, Philips, Siemens, Toshiba, and Zeiss. She completed financial executive education courses with the Wharton School of Business in Philadelphia. She worked at the Technion (Israel Institute of Technology), managing research projects in man-machine interfaces in critical systems, including in the aerospace sector (for NASA and DARPA), in computerization of military war rooms) and the healthcare sector (human errors in hospital intensive care units).
Subscribe to our mailing list
Sign up with your email address to receive news and updates.